MURIEL GUIGUI: Open Payments
NPI 1619068335 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 50 payments from 12 companies in 2025. Trend: 2023 $2,410 · 2024 $1,646 · 2025 $1,724
Food & beverage: $1,724
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $287 |
| AstraZeneca Pharmaceuticals LP | 7 | $250 |
| ABBVIE INC. | 5 | $246 |
| Amgen Inc. | 11 | $215 |
| E.R. Squibb & Sons, L.L.C. | 6 | $147 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Novartis Pharmaceuticals Corporation | 4 | $111 |
| UCB, Inc. | 4 | $88 |
| Janssen Biotech, Inc. | 3 | $77 |
| Mallinckrodt Hospital Products Inc. | 3 | $72 |
Products named: KEVZARA, SAPHNELO, RINVOQ, ORENCIA, STRENSIQ, KRYSTEXXA, COSENTYX, Bimzelx.
Industry payments across FL — which companies pay providers there.
